All Disclosures

Name Company Name Type of Disclosure Individuals Involved

Achtyes, Eric Roche Advisory committee Self

Janssen, AssurEx Health, Otsuka

Research funding Self

Allen, Michael Ferrer Consultant Self

ProPhase, LLC Employee Self

Alphs, Larry Janssen Scientific Affairs, LLC

Employee Self

ProPhase, LLC Employee Self

Johnson & Johnson Stockholder Self

Baker, Ross Otsuka Full-time employee Self

Belanoff, Joseph Corcept Therapeutics CEO Self

Bera, Rimal Otsuka Speaker Self

Burch, Ronald Naurex, Inc. Employee Self

Busner, Joan Bracket Employee Self

Childress, Ann Shire, Novartis Consultant, Speaker, Research Support

Self

Bristol-Myers Squibb Speaker, Research Support Self

NextWave, Rhodes Research Support, Consultant Self

Lilly, Forest Research Institute, Johnson and Johnson, Sepracor, Otsuka, Noven, Sunovion, Theravance, Neurovance, Neos, Arbor, Tris,, Purdue, Noven

Research Support Self

Pfizer Research Support, Advisory Board, Speaker

Self

Shionogi Advisory Board, Speaker, Research Support

Self

Ironshore Consultant, Research Support, Advisory Board

Self

Citrome, Leslie Actavis (Forest), Alexza, Alkermes, Bristol-Myers Squibb, Eli Lilly, Forum (Envivo), Genentech, Janssen, Jazz, Lundbeck, Merck, Medivation, Mylan, Novartis, Noven, Otsuka,

Consultant Self

Pfizer, Reckitt Benckiser, Reviva, Shire, Sunovion, Takeda, Teva

Bristol-Myers Squibb, Eli Lilly, Johnson and Johnson, Merck, Pfizer

Small Common Stock Holder Self

Actavis (Forest), AstraZeneca, Jazz, Lundbeck, Novartis, Otsuka, Pfizer, Shire, Sunovion, Takeda, Teva

Speaker Self

Actavis (Forest), AstraZeneca, Jazz, Lundbeck, Novartis, Otsuka, Pfizer, Shire, Sunovion, Takeda, Teva

Speakers bureau Self

Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer

Stocks (small number of shares of common stock)

Self and spouse

Clayton, Anita Ballantine Books/Random House, Guilford Publications

Royalties Self

Lundbeck, Naurex, Otsuka, Roche, Sprout Pharmaceuticals, Inc., Auspex Pharmaceuticals, Euthymics, Forest Research Institute, Inc., Lundbeck, Naurex, Otsuka, Palatin Technologies, Inc., Pfizer Inc., Roche, S1 Pharmaceuticals, Inc., Sprout Pharmaceuticals, Inc., Takeda Global Research & Development, Trimel Biopharma

Consulting fee Self

Changes in Sexual Functioning Questionnaire

Licensure fee Self

Auspex Pharmaceuticals, Forest Research Institute, Inc., Trimel Biopharma

Research grant Self

Palatin Technologies, Pfizer, Takeda Global Research & Development

Research grant, consulting fee Self

S1Biopharmaceuticals, Inc. Restricted stock units Self

Euthymics, S1 Pharmaceuticals, Inc.

Stocks, stock options, or ownership interest, excluding diversified mutual funds

Self

Cook, Ian NeuroSigma IP license with UCLA, employment, stock options

Self

NeuroSigma, NeoSync, NIH Grant support Self

Correll, Christoph AbbVie, Alkermes, Bristol-Myers Squibb, Eli Lilly, Genentech, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, Lundbeck, MedAvante, Medscape, Otsuka, Pfizer, ProPhase, Reviva, Roche, Sunovion, Supernus, Takeda

Consultant Self

Davis, Lori Tonix Research Grant Self

Otsuka, Lundbeck, Brackett Consultant Self

Detke, Michael Alkermes, Cerecor, Columbia Northwest, CoMentis, Edgemont, Embera NeuroTherapeutics, GenoMind, MedAvante, Minerva, Naurex, Neurometrix, NIH, Omeros, Roche, Sunovion, Taisho, Takeda, Tal

Consultant Self

Efros, Mitchell Verified Clinical Trials CEO/Owner Self

Eliaz, Rom Teva Pharmaceuticals Employee Self

Epstein, Irvin Janssen, Inc. Advisory board or similar committee

Self

Bristol-Myers Squibb, Takeda, Shire, Pfizer, Roche, Purdue

Clinical trial investigator Self

Evins, Eden Pfizer, GSK Research Grant Support Self

Fallu, Angelo Merck Research Self

Purdue Research; advisory board; CME Self

AstraZeneca, Janssen, Lundbeck, Pfizer, Shire, Sunovion, Valeant

Advisory Board; CME Self

Bristol-Myers Squibb Advisory Board Self

Fava, Maurizio Abbot Laboratories; Alkermes, Inc.; American Cyanamid;Aspect Medical Systems; AstraZeneca; Avanir Pharmaceuticals; BioResearch; BrainCells Inc.; Bristol-Myers Squibb; CeNeRx BioPharma; Cephalon; Clintara, LLC; Covance; Covidien; Eli Lilly and Company;EnVivo Pharmaceuticals, Inc.; Euthymics Bioscience, Inc.; Forest Pharmaceuticals, Inc.; Ganeden Biotech, Inc.; GlaxoSmithKline; Harvard Clinical Research Institute; Hoffman-LaRoche; Icon Clinical Research; i3 Innovus/Ingenix; Janssen R&D, LLC; Jed Foundation; Johnson & Johnson Pharmaceutical Research & Development; Lichtwer Pharma GmbH; Lorex Pharmaceuticals; Lundbeck Inc.; MedAvante; Methylation Sciences Inc; National Alliance for Research on Schizophrenia & Depression (NARSAD); National Center for Complementary and Alternative Medicine (NCCAM); National Institute of Drug Abuse (NIDA);

full lifetime disclosures Disclosures (lifetime): Maurizio Fava, MD (updated: Feb 2015) All disclosures can be view on line at: http://mghcme.org/faculty/faculty-detail/maurizio_fava Research Support:

Self

National Institute of Mental Health (NIMH); Neuralstem, Inc.; Novartis AG; Organon Pharmaceuticals; PamLab, LLC.; Pfizer Inc.; Pharmacia-Upjohn; Pharmaceutical Research Associates., Inc.; Pharmavite® LLC;PharmoRx Therapeutics; Photothera; Reckitt Benckiser; Roche Pharmaceuticals; RCT Logic, LLC (formerly Clinical Trials Solutions, LLC); Sanofi-Aventis US LLC; Shire; Solvay Pharmaceuticals, Inc.; Stanley Medical Research Institute (SMRI); Synthelabo; Wyeth-Ayerst Laboratories Advisory Board/ Consultant: Abbott Laboratories; Affectis Pharmaceuticals AG; Alkermes, Inc.; Amarin Pharma Inc.; Aspect Medical Systems; AstraZeneca; Auspex Pharmaceuticals; Avanir Pharmaceuticals; AXSOME Therapeutics; Bayer AG; Best Practice Project Management, Inc.; BioMarin Pharmaceuticals, Inc.; Biovail Corporation; BrainCells Inc; Bristol-Myers Squibb; CeNeRx BioPharma; Cephalon, Inc.; Cerecor; CNS Response, Inc.; Compellis Pharmaceuticals; Cypress Pharmaceutical, Inc.; DiagnoSearch Life Sciences (P) Ltd.; Dinippon Sumitomo Pharma Co. Inc.; Dov Pharmaceuticals, Inc.; Edgemont Pharmaceuticals, Inc.; Eisai Inc.; Eli Lilly and Company; EnVivo Pharmaceuticals, Inc.; ePharmaSolutions; EPIX Pharmaceuticals, Inc.; Euthymics Bioscience, Inc.;

Fabre-Kramer Pharmaceuticals, Inc.; Forest Pharmaceuticals, Inc.; Forum Pharmaceuticals; GenOmind, LLC; GlaxoSmithKline; Grunenthal GmbH; i3 Innovus/Ingenis; Janssen Pharmaceutica; Jazz Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Knoll Pharmaceuticals Corp.; Labopharm Inc.; Lorex Pharmaceuticals; Lundbeck Inc.; MedAvante, Inc.; Merck & Co., Inc.; MSI Methylation Sciences, Inc.; Naurex, Inc.; Nestle Health Sciences; Neuralstem, Inc.; Neuronetics, Inc.; NextWave Pharmaceuticals; Novartis AG;Nutrition 21; Orexigen Therapeutics, Inc.; Organon Pharmaceuticals; Otsuka Pharmaceuticals; Pamlab, LLC.; Pfizer Inc.; PharmaStar; Pharmavite® LLC.; PharmoRx Therapeutics; Precision Human Biolaboratory; Prexa Pharmaceuticals, Inc.; PPD; Puretech Ventures; PsychoGenics; Psylin Neurosciences, Inc.; RCT Logic, LLC ( formerly Clinical Trials Solutions, LLC); Rexahn Pharmaceuticals, Inc.; Ridge Diagnostics, Inc.; Roche; Sanofi-Aventis US LLC.; Sepracor Inc.; Servier Laboratories; Schering-Plough Corporation; Solvay Pharmaceuticals, Inc.; Somaxon Pharmaceuticals, Inc.; Somerset Pharmaceuticals, Inc.; Sunovion Pharmaceuticals;

Supernus Pharmaceuticals, Inc.; Synthelabo; Takeda Pharmaceutical Company Limited; Tal Medical, Inc.; Tetragenex Pharmaceuticals, Inc.; TransForm Pharmaceuticals, Inc.; Transcept Pharmaceuticals, Inc.; Vanda Pharmaceuticals, Inc. (continued) Speaking/Publishing: Adamed, Co; Advanced Meeting Partners; American Psychiatric Association; American Society of Clinical Psychopharmacology; AstraZeneca; Belvoir Media Group; Boehringer Ingelheim GmbH; Bristol-Myers Squibb; Cephalon, Inc.; CME Institute/Physicians Postgraduate Press, Inc.; Eli Lilly and Company; Forest Pharmaceuticals, Inc.; GlaxoSmithKline; Imedex, LLC; MGH Psychiatry Academy/Primedia; MGH Psychiatry Academy/Reed Elsevier; Novartis AG; Organon Pharmaceuticals; Pfizer Inc.; PharmaStar; United BioSource,Corp.; Wyeth-Ayerst Laboratories. Stock/Other Financial Options: Equity Holdings: Compellis; PsyBrain, Inc. Royalty/patent, other income: Patents for Sequential Parallel Comparison Design (SPCD), licensed by MGH to Pharmaceutical Product Development, LLC (PPD); and patent application for a combination of Ketamine plus Scopolamine in Major

Depressive Disorder (MDD), licensed by MGH to Biohaven. Copyright for the MGH Cognitive & Physical Functioning Questionnaire (CPFQ), Sexual Functioning Inventory (SFI), Antidepressant Treatment Response Questionnaire (ATRQ), Discontinuation-Emergent Signs & Symptoms (DESS), Symptoms of Depression Questionnaire (SDQ), and SAFER; Lippincott, Williams & Wilkins; Wolkers Kluwer; World Scientific Publishing Co. Pte.Ltd.

BMS Advisory board self

AstraZeneca, Janssen, Lundbeck, Pfizer, Shire, Sunovion, Valeant

Advisory board; CME self

Abbott Laboratories; Affectis Pharmaceuticals AG; Alkermes, Inc.; Amarin Pharma Inc.; Aspect Medical Systems; AstraZeneca; Auspex Pharmaceuticals; Bayer AG; Best Practice Project Management, Inc.; BioMarin Pharmaceuticals, Inc.; Biovail Corporation; BrainCells Inc; Bristol-Myers Squibb; CeNeRx BioPharma; Cephalon, Inc.; Cerecor; CNS Response, Inc.; Compellis Pharmaceuticals; Cypress Pharmaceutical, Inc.; DiagnoSearch Life Sciences (P) Ltd.; Dinippon Sumitomo Pharma Co. Inc.; Dov Pharmaceuticals, Inc.; Edgemont Pharmaceuticals, Inc.; Eisai Inc.; Eli Lilly and Company; EnVivo Pharmaceuticals, Inc.;

Advisory/Consulting Self

ePharmaSolutions; EPIX Pharmaceuticals, Inc.; Euthymics Bioscience, Inc.; Fabre-Kramer Pharmaceuticals, Inc.; Forest Pharmaceuticals, Inc.; GenOmind, LLC; GlaxoSmithKline; Grunenthal GmbH; i3 Innovus/Ingenis; Janssen Pharmaceutica; Jazz Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Knoll Pharmaceuticals Corp.; Labopharm Inc.; Lorex Pharmaceuticals; Lundbeck Inc.; MedAvante, Inc.; Merck & Co., Inc.; MSI Methylation Sciences, Inc.; Naurex, Inc.; Neuralstem, Inc.; Neuronetics, Inc.; NextWave Pharmaceuticals; Novartis AG;Nutrition 21; Orexigen Therapeutics, Inc.; Organon Pharmaceuticals; Otsuka Pharmaceuticals; Pamlab, LLC.; Pfizer Inc.; PharmaStar; Pharmavite® LLC.; PharmoRx Therapeutics; Precision Human Biolaboratory; Prexa Pharmaceuticals, Inc.; Puretech Ventures; PsychoGenics; Psylin Neurosciences, Inc.;RCT Logic, LLC ( formerly Clinical Trials Solutions, LLC); Rexahn Pharmaceuticals, Inc.; Ridge Diagnostics, Inc.; Roche; Sanofi-Aventis US LLC.; Sepracor Inc.; Servier Laboratories; Schering-Plough Corporation; Solvay Pharmaceuticals, Inc.; Somaxon Pharmaceuticals, Inc.; Somerset Pharmaceuticals, Inc.;

Sunovion Pharmaceuticals; Supernus Pharmaceuticals, Inc.; Synthelabo; Takeda Pharmaceutical Company Limited; Tal Medical, Inc.; Tetragenex Pharmaceuticals, Inc.; TransForm Pharmaceuticals, Inc.; Transcept Pharmaceuticals, Inc.; Vanda Pharmaceuticals, Inc.

Compellis; PsyBrain, Inc. Equity Holdings Self

Purdue Research; advisory board; CME self

Patent for Sequential Parallel Comparison Design (SPCD), which are licensed by MGH to Pharmaceutical Product Development, LLC (PPD); and patent application for a combination of Ketamine plus Scopolamine in Major Depressive Disorder (MDD). Copyright for the MGH Cognitive & Physical Functioning Questionnaire (CPFQ), Sexual Functioning Inventory (SFI), Antidepressant Treatment Response Questionnaire (ATRQ), Discontinuation-Emergent Signs & Symptoms (DESS), and SAFER; Lippincott, Williams & Wilkins; Wolkers Kluwer; World Scientific Publishing Co. Pte, Ltd.

Royalty/patent, other income Self

Adamed, Co; Advanced Meeting Partners; American Psychiatric Association; American Society of Clinical Psychopharmacology; AstraZeneca; Belvoir Media

Speaking/Publishing Self

Group; Boehringer Ingelheim GmbH; Bristol-Myers Squibb; Cephalon, Inc.; CME Institute/Physicians Postgraduate Press, Inc.; Eli Lilly and Company; Forest Pharmaceuticals, Inc.; GlaxoSmithKline; Imedex, LLC; MGH Psychiatry Academy/Primedia; MGH Psychiatry Academy/Reed Elsevier; Novartis AG; Organon Pharmaceuticals; Pfizer Inc.; PharmaStar; United BioSource,Corp.; Wyeth-Ayerst Laboratories.

Freeman, Marlene

Takeda Research Grant (pending) Self

Takeda, Otsuka, Lundbeck, Genentech, JDS therapeutics

Advisory Boards Self

GOED Medical Editing Self

Garibaldi, George F. Hoffman La Roche Employee Self

Gelenberg, Alan Zynx Health, Bloom Burton & Company, U.S. Food & Drug Administration

Consultant Self

Ballard Spahr, LLP (on behalf of Glaxo SmithKline

Expert Witness Self

Healthcare Technology Systems, Inc.

Stock Ownership Self

Gerard, Elizabeth SAGE pharmaceuticals Clinical Trial - Site PI Self

UCB Clinical Trial- Consultant Self

Glick, Ira Johnson and Johnson Equity Self

Otsuka, Lundbeck Consultant Self

Eli Lilly, EnVivo, Alkermes, Janssen, Recketts, Otsuka

Research support Self

Takeda, Sunovion Speaker's bureau Self

Frontline Medical Communications

Editorial stipend Self

American Psychiatric Publishing, Inc.

Royalties Self

Goldman, Robert Sunovion Pharmaceuticals, Inc.

Employee Self

Harvey, Philip Forum Pharma, Genentech, Boeheringer-Ingelheim, Otsuka-America, Roche, Sunovion Pharma, Takeda Pharma, Lundbeck Pharma

Consultant Self

Astra-Zeneca Grant Self

Abbott Labs, Amgen, Boeheringer Ingelheim, Bristol-Myers-Squibb, Forest Labs, Genentech, Johnson and Johnson, Pharma Neuroboost, Roche, Shire, Sunovion, Takeda

Advisory Board/consultant Self

Karp, Jordan Pfizer, Reckitt Benckiser Receipt of medication supplies for investigator initiated study

Self

Katzman, Martin Canadian Institutes of Health Research, Sick Kids Foundation, Centre for Addiction and Mental Health Foundation, Canadian Psychiatric Research Foundation, Canadian Foundation for Innovation

Grant Self

START Clinic for Mood and Anxiety Disorders

Clinic Director Self

Pfizer, Reckitt Benckiser Receipt of medication supplies for investigator initiated study

Self

Takeda, Roche, Purdue, Boehringer Ingelheim, Biovail

Study investigator Self

GlaxoSmithKline, Inc., Wyeth Pharmaceuticals, Lundbeck Canada, Eli Lilly, Organon, AstraZeneca, Janssen-Ortho, Inc., Solvay, Genuine Health, Shire, Bristol Myers Squibb, Pfizer

Study investigator; advisory board/committee

Self

Keefe, Richard Abbvie, Akebia, Amgen, Asubio, AviNeuro/ChemRar, Biogen, Idec, Biomarin, Boehringer-Ingelheim, FORUM, GW Pharmaceuticals, Lundbeck, Merck, Minerva Neurosciences, Inc.,

Consulting Self

Mitsubishi, Novartis, Otsuka, Pfizer, Roche, Sunovion, Takeda

Department of Veteran's Affairs, NIMH, Singapore Medical Research Council

Research funding Self

BACS testing battery, MATRICS Battery (BACS Symbol Coding), Virtual Reality Functional Capacity Assessment Tool (VRFCAT)

Royalties received Self

Neurocog Trials, Inc., Sengenix

Shareholder Self

Ketter, Terence Sunovion Pharmaceuticals

Research Contract Self

ProPhase, Teva Pharmaceuticals

Consultant Self

Pfizer Pharmaceuticals Lecture Honoraria Self

American Psychiatric Publishing, Inc.

Royalties Self

Janssen Pharmaceuticals Employee, Stockholder Self

Agency for Healthcare Research and Quality

Research Contract Self

Kirkpatrick, Brian ProPhase Consulting Self

Klassen, Larry AstraZeneca, Bristol Myers Squibb, Eli Lilly, JOI, Lundbeck, Pfizer, Shire

Consultant; study investigator Self

Krystal, Andrew Abbott, AstraZeneca, Attentiv, Teva, Eisai, Eli Lilly, Jazz, Janssen, Merck, Neurocrine, Novartis, Otsuka, Pfizer, Lundbeck, Roche, Sunovion, Paladin, Pernix, Transcept.

Consultant Self

NIH, Teva, Sunovion, Astellas, Neosync, Brainsway, Janssen, ANS St. Jude, Novartis, Azevan, Eisai.

Grant/research support Self

Laughren, Thomas P.

AbbVie, Acadia, Alcobra, Astra Zeneca, Axsome, Camurus, Cerecor, Corcept, Curemark, Dart NeuroScience, Delpor, Durect, Edgemont, EnVivo, ERT, Fabre Kramer, Gedeon

Consultant Self

Richter, Janssen, JDS Therapeutics, Eli Lilly, MAPS, MedAvante, Medgenics, Naurex, Neuren, Neurocrine, Biosciences, NIMH, Noven, Omeros, Pfizer, Quinn Emanuel Law Firm, Retrophin, Reviva, Roche, Salamandra, Shire, Spinifex, Sunovion, Taisho, Targacept, Teva, Theravance, Tonix, Transition Therapeutics, Ulmer & Berne Law Firm, Zogenix

MGH CTNI Employee Self

Legacy, Susan Otsuka America Pharmaceutical, Inc.

Employee Self

Liebowtiz, Michael

Pherin Pharmaceuticals stock options, employee, consultant

Self

Liebowitz Social Anxiety Scale

copyright holder Self

Lindenmayer, Jean-Pierre

Pfizer, Forum, Roche, Neurocrine, Alkermes, Amgen

Research Grant Self

Janssen Consultant Self

MultiHealth Systems Royalties Self

Malhotra, Anil Forum Pharmaceuticals Consultant Self

Genomind, Inc. Advisory Board Self

Marder, Stephen Abbvie Inc., Boehringer Ingelheim GmbH, FORUM Pharmaceuticals, Genetech inc, Roche, H. Lundbeck A/S, Hoffman-La Roche inc., Otsuka Pharmaceutical Co. Ltd., Pfizer inc., Synchroneuron inc., Targacept inc.

Consultant Self

Amgen inc., Genentech, Roche, Sunovian Pharmaceuticals inc.

Grant/research support Self

Sunovion, Amgen Research Support

Marshall, Fiona Heptares Therapeutics Ltd Founder, share holder, employee Fiona Marshall

Mathew, Sanjay Naurex, Cerecor, Genentech consultant Self

Sanofi-Aventis Research drug provided for NIH study

Self

Janssen Research Grant Self

McEvoy, Joseph Auspex, Alkermes research grant Self

Ameritox, Otsuka ad board, research grant Self

EnVivo/Forum, Merck, Jazz ad board Self

Moore, Christine Inventiv Health Clinical employee Self and spouse

Nelson, J. Craig Otsuka (Asia), Bristol Myers Squibb (Canada), Genentech

Honoraria Self

Corcept, Lundbeck, Pfizer Consultant Self

Avid Research Support Self

Atossa Stock Self

Nemeroff, Charles

Xhale Consultant, Stockholder, Scientific Advisory Board

Self

Takeda, SK Pharma, Shire, Roche, Lilly, Allergan, Mitsubishi Tanabe, Taisho Pharmaceutical, Lundbeck, Prismic, Total Pain Solutions, BMS, Corcept, Pfizer, Sunovion

Consultant Self

Clintara Consultant, Scientific Advisory Board

Self

Celgene, Seattle Genetics, Abbvie, Titan Pharmaceuticals

Stockholder Self

AFSP, ADAA Scientific Advisory Board, Board of Directors

Self

Newcorn, Jeffrey Alcobra, Biobehavioral Diagnostics, GencoSciences, Ironshore, Lupin, Neurovance, Alcobra

Advisor/Consultant Self

Genentech advisor, honorarium Self

Shire Advisor/Consultant/Research Support

Self

Eli Lilly, Genentech Advisory Board Self

Gratitude America Board of Directors Self

Lundbeck, Otsuka consultant, honorarium Self

Bristol-Myers Squibb, Merck, Vivus

Data Safety Monitoring Board Self

NIH Grant funding Self

American Physician Institute, CME Outfitters, CMEology, American Psychiatric Association

Honoraria Self

Method and devices for transdermal delivery of lithium (US 6,375,990B1), Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)

Patent Self

NIMH, HRSA, Avid Research Support Self

Jones and Bartlett Publishing

Royalties Self

Skyland Trail, RiverMend, BBRF

Scientific Advisory Board Self

Atossa Stock Ownership Self

Opler, Mark Multi Health Systems Royalties Self

Papakostas, George

Lundbeck, Eli Lily, Avanir, Takeda, Brainsway

Honoraria, Consultant Self

GlaxoSmithKline, Meiji Seika Honoraria Self

Pfizer, Forest, NIMH Research Support Self

Genentech Consultant Self

Paterson, Blake Cerecor, Inc. Employee Self

Phillips, Katharine

Oxford University Press, American Psychiatric Publishing, Merck Manual

Royalties or Honoraria Self

Abbott Laboratories, Astra Zeneca

Honorarium for a presentation that did not involve company products

Self

Potkin, Steven Otsuka; Sunovion; Roche; Lundbeck; FORUM; Alkermes

Consultant/Advisory Board Self

Potter, William Ironwood, Amgen, Alkermes, Taisho

Consultant Self

Lilly, Takeda Advisory Board Self

Lundbeck, Roche Consultant/Advisory Board Self

Sunovion Speaker Bureau Self

Pyke, Robert S1 Biopharma, Inc. Regular employee Self

Rabinowitz, Jonathan

JNJ, Roche, Avraham Pharm, BiolineRX, Amgen, Lilly, Ethypharm

Consultant Self

MedAvante Member of Scientific Board Self

DupCheck.org Own the site, it is currently available for free use. I may monetize in the future.

Self

Eli Lilly Research support Self

Reynolds, Charles Bristol Myeres Squibb, Lily, Forest Labs, Pfizer

Provided pharmaceutical supplies for NIH-sponsored work. The pharmaceutical companies play no role in the design, analysis, or reporting of my data in peer reviewed journals.

Self

Robinson, Delbert Otsuka Grant support Self

Rubin, Jonathan Alcobra Ltd Stock options Self

Sajatovic, Martha Pfizer, Merck, Janssen Grant Funding Self

Pfizer, Otsuka, Amgen, Bracket, Prophase

Consultant Self

Sanacora, Gerard AstraZeneca, Eli Lilly & Co, Hoffman La-Roche, Naurex

Advisory Board, Contracted Research

Self

Avanier Pharmaceuticals; Noven Pharmaceuticals

Consulting Self

Bristol-Myers Squibb, Merck Consulting, Contracted Research Self

Servier Contracted Research Self

Sanofi-Aventis Free medications was provided for a study

Self

Biohaven Pharmaceutical Holding Company

Shares Self

Saunders, Erika Profiles In Knowledge consultant Self

Schooler, Nina EnVivo/Forum, Roche, Sunovion

Advisory Board Self

Genentech, Otsuka, Neurocrine

Research Grant Self

Cerecor, Inc., Forest Pharmaceuticals, Janssen Pharmaceutica, Medtronic, Inc., Naurex, Inc., Pamlab, Inc., Ridge Diagnostics, Takeda Pharmaceuticals

Consulting, grant Self

Assurex Health, Avanir Pharmaceuticals, Novartis Pharmaceuticals, Otsuka Pharmaceuticals

Grant Self

Shelton, Richard Bristol-Myers Squibb Company, Cerecor, Inc., Forest Pharmaceuticals, Janssen Pharmaceutica, Naurex, Inc., Pamlab, Inc., Takeda Pharmaceuticals

Consultant, Research Support Self

Clintara, LLC, Cyberonics, Inc., Medtronic, Inc., MSI Methylation Sciences, Inc., Pfizer, Inc., Ridge Diagnostics, Shire Plc

Consultant Self

Alkermes, Inc., Assurex Health, Avanir Pharmaceuticals, Inc., Elan, Corp., Novartis Pharmaceuticals, Otsuka Pharmaceuticals

Research Support Self

Shiovitz, Thomas CTSdatabase, LLC Ownership interest Self

Silverman, Bernard

Alkermes, Inc employee, shareholder Self

Singh, Jaskaran Janssen R&D Employee Self

Soares, Jair Roche consultant Self

Forest, BMS Research Self

Stein, Mark Alcobra Advisor Self

Genco Sciences Consultant Self

Alcobra, Shire, Pfizer Research Support Self

Thase, Michael E. Alkermes, AstraZeneca, Avenir, Bristol-Myers Squibb Company, Eli Lilly & Co, Forest Laboratories, Gerson Lehman Group, GlaxoSmithKline, Guidepoint Global, H. Lundbeck A/S, Johnson & Johnson, MedAvante, Merck and Co., Naurex, Neuronetics, Inc., Otsuka, Pfizer, Roche, Shire US, Inc., Sunovion Pharmaceuticals, Inc., Takeda

Consultant/advisory board Self

Peloton Advantage Employee Spouse

MedAvante Equity Holdings Self

Agency for Healthcare Research and Quality, Alkermes (ended Feb 2013), Forest, National Institute of Mental Health, Otsuka, PharmaNeuroboost (ended March 2013), Roche (ended June 2013)

Grant Support Self

Alkermes, AstraZeneca, Avenir, Eli Lilly & Co, Forest Laboratories, Johnson & Johnson, Otsuka

Grant/research support Self

Peloton Advantage Other/Spouse Spouse

American Psychiatric Foundation, Guilford Publications, Herald House, WW Norton & Co

Royalties Self

MedAvante, American Psychiatric Foundation, Guilford Publications, Herald House, W.W. Norton & Company, Inc.

Stock/other financial disclosure Self

Tillisch, Kirsten Tsumura, Inc grant funding Self

Trivedi, Madhukar

J&J Pharmaceuticals, Takeda Pharmaceuticals, Genentech, Lundbeck,

Advisor Self

Pfizer, Cerecor, Alkremis, Naurex, Merck

Umbricht, Daniel F. Hoffmann - la Roche, Ltd. Employee Self

Vanover, Kimberly

Intra-Cellular Therapies Employee Self

Wisner, Katherine Quinn Emanuel The Department of Psychiatry at Northwestern University receives contractual fees for Dr. Wisner's consultation to Quinn Emanuel Urquhart & Sullivan, LLP (New York City), who represent Pfizer Pharmaceutical Company.

Self

Yang, Lawrence Prophase Training Consultant Self

Yonkers, Kimberly

Up To Date Author Self

Zammit, Gary Astra Zeneca, Biomarin, Novo Nordisk, Takeda, Lilly, Neurocrine Biosciences, Jazz, Eisai, Balance Therapeutics, Roxane, Edgemont, Dart, Janssen, Taisho, Novartis, Pfizer, Cubist, Otsuka, Neostem, CHDI, Abbvie, Alkermes

Research Self

Zarate, Carlos NIMH Patent on ketamine depression Self

Zeller, Scott Teva Consultant Self

The following individuals had nothing to disclose:

Beversdorf, David Blaise, J H Bradley, Kailyn Brady, Chris Burghardt, Paul Chacko, Anil Chang, Christina Clark, Crystal Cunningham, Kathryn Currier, Glenn De Lucena, David de Quevedo, João Edwards, Emmeline Farchione, Tiffany Fernandez-Mendoza, Julio Gama, Clarissa Gareau, Melanie

Gass, Margery Gaynes, Bradley Hallak, Jamie Halperin, Jeffrey Hensley, Paula Jack, Allison Kapczinski, Flavio Laezza, Fernanda Leavitt, Molly Lippman, Marc Macedo, Danielle Meyers, Barnett Mohite, Satyajit Monte, Aline Montoya, Ivan Mukhametshina, Elvira Murray, Michael

Nicolato, Rodrigo Opler, Mark Rapaport, Mark Renner, Deborah Romano-Silva, Marco Satler Diniz, Breno Sedway, Jan Selvaraj, Sudhakar Shurtleff, David Sit, Dorothy Skolnick, Phil Teixeira, Antonio Walz, Roger Weingard, Kerri Young, Robert Zalcman, Steven